EPSTEIN BARR VIRUS IGG ANTIBODIES, EBV (NA) (INFECTIOUS MONONUCLEOSIS)

The Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA) IgG Antibodies Test is a specialized blood test that detects IgG antibodies against the Epstein-Barr Virus Nuclear Antigen (EBNA). This test helps determine whether a person has had a previous Epstein-Barr virus (EBV) infection and plays an important role in interpreting the stage of EBV infection when used as part of a complete EBV antibody profile.

Epstein-Barr virus is a common member of the herpesvirus family and is the primary cause of infectious mononucleosis (glandular fever). Most people become infected at some point during their lives. After the initial infection, the virus remains dormant in the body for life. Although many individuals recover completely, EBV can occasionally reactivate, particularly in people with weakened immune systems.

Unlike Viral Capsid Antigen (VCA) IgM antibodies, which appear early during infection, EBNA IgG antibodies generally become detectable 2–4 months after the initial infection has resolved and usually remain present for life. Therefore, the presence of EBNA IgG antibodies typically indicates past infection rather than an active illness.

The EBNA IgG test is commonly interpreted together with EBV VCA IgM, VCA IgG, and Early Antigen (EA) IgG tests. Evaluating all these antibodies together helps healthcare providers distinguish between acute infection, recent infection, past infection, and possible viral reactivation.

Doctors may recommend this test for individuals with prolonged fatigue, fever, swollen lymph nodes, sore throat, or when infectious mononucleosis is suspected. It is also useful for evaluating unexplained viral illnesses and confirming previous exposure to EBV.

Benefits of the Test

• Identifies previous Epstein-Barr virus infection.
• Measures long-lasting EBNA IgG antibodies.
• Helps differentiate past infection from acute infection.
• Supports interpretation of the complete EBV antibody profile.
• Assists in diagnosing infectious mononucleosis.
• Useful in evaluating unexplained fatigue and viral illness.
• Requires only a simple blood sample.
• Provides reliable laboratory results using validated immunological methods.

Why Doctors Recommend This Test

Doctors recommend the EBV Nuclear Antigen (EBNA) IgG Antibodies Test to determine whether a patient has had a previous EBV infection. It is particularly useful when evaluating infectious mononucleosis or persistent viral symptoms. When combined with other EBV antibody tests, it helps establish the stage of infection and guides appropriate clinical management.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise by your healthcare provider. Inform your doctor about your symptoms, previous EBV infection, immune disorders, medications, or recent illnesses. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 2–5 Working Days

Reporting time may vary depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected infectious mononucleosis.
• Patients with prolonged fatigue or unexplained fever.
• People with swollen lymph nodes and sore throat.
• Individuals requiring EBV antibody profiling.
• Patients with suspected previous EBV infection.
• Immunocompromised individuals requiring EBV evaluation.
• Patients with unexplained viral illnesses.
• Individuals referred by infectious disease specialists.
• People requiring confirmation of past EBV exposure.
• Anyone advised by their healthcare provider to undergo EBV serology testing.